Policy | July 07, 2025
Dr. Jitendra Singh inaugurates 'National Biobank' at CSIR-IGIB
CSIR-IGIB advances indigenous CRISPR Trials on sickle cell anaemia, anti-microbial resistance, liver fibrosis and rare disorders
CSIR-IGIB advances indigenous CRISPR Trials on sickle cell anaemia, anti-microbial resistance, liver fibrosis and rare disorders
The facility will manufacture 13,200 MTPA Benzyl Chloride, 9,600 MTPA Benzyl Alcohol, and 7,200 MTPA Benzaldehyde
The site, spanning approximately 25,000 square meters, is expected to commence operations by the end of 2025
Extended lab space for product development, customer demos, and training
Eylea 8 mg is the first and only anti-vascular endothelial growth factor (VEGF) treatment in the EU with treatment intervals of up to 6 months for both patients with nAMD and DME
The NovaSeq X system features Illumina's cutting-edge XLEAP-SBS chemistry, offering unmatched throughput, accuracy, and sustainability
Viatel bioresorbable polymers are increasingly used in dental and orthopedic implants
The Swiss peptide and oligonucleotide manufacturers roll out major investments across site networks in US, UK and Switzerland
This is the second and final phase of the overall capacity addition of ?195 kL which was under construction at Unit IV Bidar facility
UFlex is the first and only Indian company to receive USFDA approval for its technology and capacity to recycle all three materials
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
